Highland Capital Management LLC Decreases Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Highland Capital Management LLC trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,655 shares of the biotechnology company’s stock after selling 353 shares during the period. Highland Capital Management LLC’s holdings in Axon Enterprise were worth $3,334,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. ICA Group Wealth Management LLC purchased a new position in Axon Enterprise in the 4th quarter valued at about $26,000. Trivant Custom Portfolio Group LLC bought a new position in shares of Axon Enterprise during the first quarter worth about $31,000. BKM Wealth Management LLC bought a new position in shares of Axon Enterprise during the fourth quarter worth about $32,000. First PREMIER Bank bought a new position in shares of Axon Enterprise during the first quarter worth about $33,000. Finally, Key Financial Inc lifted its position in shares of Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the sale, the director now owns 1,607 shares in the company, valued at $498,282.49. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the sale, the director now owns 1,607 shares in the company, valued at $498,282.49. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 44,000 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the sale, the president now owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 89,447 shares of company stock valued at $27,684,677. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 0.5 %

NASDAQ:AXON traded up $1.50 during trading hours on Friday, hitting $292.66. The stock had a trading volume of 289,565 shares, compared to its average volume of 410,101. Axon Enterprise, Inc. has a one year low of $175.37 and a one year high of $329.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91. The company has a market cap of $22.09 billion, a price-to-earnings ratio of 85.57 and a beta of 0.95. The business’s 50 day moving average is $292.57 and its 200-day moving average is $287.78.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. During the same quarter in the prior year, the firm earned $0.51 earnings per share. The firm’s revenue was up 34.3% compared to the same quarter last year. Sell-side analysts anticipate that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Analyst Ratings Changes

AXON has been the topic of several research reports. JMP Securities reiterated a “market outperform” rating and set a $375.00 price objective on shares of Axon Enterprise in a research note on Tuesday, May 7th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Craig Hallum raised their price target on shares of Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. JPMorgan Chase & Co. increased their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. Finally, Barclays lifted their price target on shares of Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 8th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $335.27.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.